Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Sinovac Strikes Deal for Healive® in the Ukraine

publication date: Sep 15, 2008

Sinovac Biotech has licensed the Biolik Biopharmaceutical Company, a Ukraine-located vaccine manufacturer, to conduct clinical trials of Healive®, Sinovac’s inactivated hepatitis A vaccine, in the Ukraine. Biolik, which will market and distribute Healive in the Ukraine after it obtains regulatory clearance, estimates the eventual market for Healive in the Ukraine at $10 million annually. Thus far in its corporate history, Sinovac has not been aggressive in promoting its products outside of China. More details...

Stock Symbol: (AMEX: SVA)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital